Skip to content
Menu
Home
About Us
Board of Directors
Management Team
Technology
Clinical programs
Non-clinical programs
Intellectual property
News/Resources
Newsletters
In the news
Scientific Presentations
Scientific Publications
Investor Centre
ASX Announcements
Financial Reports
Annual
Half-year
Quarterly
Corporate Directory
Shareholder services
Rights Issue
Top 40 Shareholders
Top 40 Option Holders
Corporate Governance
Corporate Presentations
Contacts
Research
17 Apr 2012
Bell Potter Securities Limited – Benefiting from the Hepatitis C gold rush